Contrasts between the effects of zinc-α2-glycoprotein, a putative β3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice

Role of β-Adrenergic Receptors in the Oral Activity of Zinc-α2-Glycoprotein (ZAG)

(2012) Steven T. Russell et al.   ENDOCRINOLOGY

Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG)

(2011) Steven Thomas Russell et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Challenges in β3-adrenoceptor agonist drug development

(2011) Jonathan R. S. Arch   Therapeutic Advances in Endocrinology and Metabolism

Mechanism of Attenuation of Skeletal Muscle Atrophy by Zinc-α2-Glycoprotein

(2010) Steven T. Russell et al.   ENDOCRINOLOGY

Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids

(2010) Mohamed S. Zaibi et al.   FEBS LETTERS

Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse

(2010) S T Russell et al.   INTERNATIONAL JOURNAL OF OBESITY

Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?

(2010) C Bing et al.   INTERNATIONAL JOURNAL OF OBESITY

Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes

(2010) D. Gao et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The adipokine zinc-α2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity

(2009) T. Mracek et al.   CLINICAL ENDOCRINOLOGY

Antidiabetic Properties of Zinc-α2-Glycoprotein inob/obMice

(2009) Steven T. Russell et al.   ENDOCRINOLOGY

Lower Zinc-α2-Glycoprotein Production by Adipose Tissue and Liver in Obese Patients Unrelated to Insulin Resistance

(2009) David M. Selva et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating and Adipose Tissue Gene Expression of Zinc-α2-Glycoprotein in Obesity: Its Relationship with Adipokine and Lipolytic Gene Markers in Subcutaneous and Visceral Fat

(2009) V. Ceperuelo-Mallafré et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Downregulation of zinc-α2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-α in adipocytes

(2009) T Mracek et al.   JOURNAL OF ENDOCRINOLOGY

ZAG, a lipid mobilizing adipokine, is downregulated in human obesity

(2009) M. P. Marrades et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from β3-adrenoceptor agonists

(2008) Jonathan R. S. Arch   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY